Phase II study of pegylated liposomal doxorubicin (Caelyx™) as induction chemotherapy for patients with squamous cell cancer of the head and neck
| Autor: | Harrington, K.J, Lewanski, C, Northcote, A.D, Whittaker, J, Peters, A.M, Vile, R.G, Stewart, J.S.W |
|---|---|
| Zdroj: | In European Journal of Cancer November 2001 37(16):2015-2022 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect